Browse by Combined Author & Editor

Up a level
Export as [feed] RSS
Number of items: 20.

Forster, Richard, Yiqing, Tang, Bowyer, Cressida, LLOYD, ANDREW, MACFARLANE, WENDY, PHILLIPS, GARY and Lewis, Andrew (2012) Development of a combination drug-eluting bead: towards enhanced efficacy for locoregional tumour therapies Anti-Cancer Drugs, 23 (4). ISSN 0959-4973

Ferris, W.F., Marriott, C.E., Ali, T., Landy, C., Campbell, S.C. and Macfarlane, W.M. (2011) Tumor suppressor PDCD4 is a major transcript that is upregulated during in vivo pancreatic islet neogenesis and is expressed in both beta-cell and ductal cell lines Pancreas, 40 (1). pp. 61-66. ISSN 0885-3177

Forster, R.E.J., Small, S.A., Tang, Y., Heaysman, C.L., LLOYD, ANDREW, MACFARLANE, WENDY, PHILLIPS, GARY, Antonijevic, M.D. and Lewis, A.L. (2010) Comparison of DC Bead-irinotecan and DC Bead-topotecan drug eluting beads for use in locoregional drug delivery to treat pancreatic cancer Journal of Materials Science: Materials in Medicine, 21 (9). pp. 2683-2690. ISSN 0957-4530

Forster, R.E.J., Thurmer, F., Wallrapp, C., LLOYD, ANDREW, MACFARLANE, WENDY, Phillips, G.J., Boutrand, J.-P. and Lewis, A.L. (2010) Characterisation of physico-mechanical properties and degradation potential of calcium alginate beads for use in embolisation Journal of Materials Science: Materials in Medicine, 21 (7). pp. 2243-2251. ISSN 0957-4530

Ali, T., Landy, C., Marriott, C.E., Harrison, M. and Macfarlane, W.M. (2010) Imagining beta-cell lipotoxicity Diabetic Medicine, 27 (38). p. 5. ISSN 0742-3071

MACFARLANE, WENDY, HARRISON, MOIRA and MARRIOTT, CLAIRE (2009) Mucin proteins form a key component of the extracellular matrix of three dimensional Min6 cell clusters Diabetes, 58. A623. ISSN 0012-1797

Ali, T., Landy, C., Marriott, C.E., Harrison, M. and Macfarlane, W.M. (2009) Rosiglitazone down-regulates p38 stress activated kinase and prevents pancreatic beta cells from lipotoxicity-induced dysfunction Diabetic Medicine, 26 (s1). p. 6. ISSN 0742-3071

Macfarlane, W.M. (2009) Pancreas biology, pathology and tissue engineering In: Santin, M., ed. Strategies in regenerative medicine: integrating biology with materials design. Springer, New York, USA.

Aldibbiat, A., Marriott, C.E., Scougall, K.T., Campbell, S.C., Huang, G.C., Macfarlane, W.M. and Shaw, J.A.M. (2008) Inability to process and store proinsulin in transdifferentiated pancreatic acinar cells lacking the regulated secretory pathway Journal of Endocrinology, 196. pp. 33-43. ISSN 0022-0795

Landy, C., Ali, T., Crawford, R., Marriott, C.E., Woollhead, A.M., Harrison, M. and Macfarlane, W.M. (2008) Rosiglitazone modulates multiple signalling pathways in pancreatic beta cells and protects beta cells from the detrimental effects of free fatty acids Diabetes, 57 (Supplement 1A). p. 467. ISSN 0012-1797

Ali, T., Landy, C., Marriott, C.E., Crawford, R., Woollhead, A.M., Harrison, M. and Macfarlane, W.M. (2008) Rosiglitazone prevents fatty acid induced increases in uncoupling protein 2 gene expression and protects pancreatic beta-cells from lipotoxicity Acta Diabetologica, 51. p. 200. ISSN 0940-5429

Campbell, S.C., Aldibbiat, A., Marriott, C., Landy, C., Ali, T., Ferris, W.F., Butler, C.S., Shaw, J.A. and Macfarlane, W.M. (2008) Selenium stimulates pancreatic beta cell gene expression and enhances islet function FEBS Letters, 582 (15). pp. 2333-2337. ISSN 0014-5793

Campbell, S.C., Richardson, H., Ferris, W.F., Butler, C.S. and Macfarlane, W.M. (2007) Nitric oxide stimulates insulin gene transcription in pancreatic beta-cells Biochemical and Biophysical Research Communications, 353 (4). pp. 1011-1016. ISSN 1090-2104

Richardson, H., Campbell, S.C., Smith, S.A. and Macfarlane, W.M. (2006) Effects of rosiglitazone and metformin on pancreatic beta cell gene expression Diabetologia, 49 (4). pp. 685-696. ISSN 1432-0428

Macfarlane, W.M (2006) Approaches to beta-cell regeneration and neogenesis In: Shapiro, E and Shaw, J, eds. Islet transplantation and beta-cell replacement therapy. Marcel Dekker Inc.

Richardson, H., Campbell, S.C., Smith, S.A. and Macfarlane, W.M. (2006) Effects of Rosiglitazone and Metformin on pancreatic beta-cell gene expression Diabetologia, 49 (4). pp. 685-696. ISSN 0012-186X

Ferris, W.F., van der Merwe, L., Campbell, S.C. and Macfarlane, W.M. (2005) Glucocorticoid administration and brief occlusion of the main pancreatic duct are likely to increase islet mass by a similar mechanism Pancreas, 31 (2). pp. 132-137. ISSN 0885-3177

Shepherd, L.M.A., Campbell, S.C. and Macfarlane, W.M. (2004) Transcriptional regulation of the IAPP gene in pancreatic beta-cells Biochimica Et Biophysica Acta-Gene Structure and Expression, 1681 (1). pp. 28-37. ISSN 0167-4781

Campbell, S.C. and Macfarlane, W.M. (2002) Regulation of the pdx1 gene promoter in pancreatic beta-cells Biochemical and Biophysical Research Communications, 299 (2). pp. 277-284. ISSN 1090-2104

Weng, J., Macfarlane, W.M., Lehto, M., Gu, H.F., Shepherd, L.M., Ivarsson, S.A., Wibell, L., Smith, T. and Groop, L.C. (2001) Functional consequences of mutations in the MODY4 gene (IPF1) and coexistence with MODY3 mutations Diabetologia, 44 (2). pp. 249-258. ISSN 1432-0428

This list was generated on Sat Nov 22 13:33:04 2014 GMT.